logologo
QuantliQuantli

Arrowhead Pharmaceuticals Inc

ARWR

NASDAQ

Biotechnology

$86.64

USD

+1.05 (+1.23%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $12.21B

Volume 817.8K

Price Target

$72.00$115.00

USD

The 4 analysts offering 1-year price forecasts have a max estimate of $115.00 and a min estimate of $72.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$93.75

+$9.5 vs prior

Implied Upside

+8.2%

+11.0% vs prior

Analyst Covering

4

-1 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

44%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$0.2500 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

3 Buy

1 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

3

Hold

1

Sell

0

Strong Sell

0

4 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Patrick R. Trucchio

HC Wainwright & Co.

Buy

Maintained

2 weeks ago

Plus
Plus
Plus

James Condulis

Stifel

Buy

Initiated

4 weeks ago

Plus
Plus
Plus

Keay Nakae

Chardan Capital

Buy

Maintained

1 month ago

Plus
Plus
Plus

Mani Foroohar

Leerink Swann

Hold

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

NBIX

Neurocrine Biosciences Inc

$152.72

+1.3%

SMMT

Summit Therapeutics Inc

$13.35

-4.6%

BMRN

BioMarin Pharmaceutical Inc

$67.36

-1.7%

BBIO

BridgeBio Pharma Inc

$79.86

-1.7%

PRAX

Praxis Precision Medicines Inc

$366.81

-0.5%

EXEL

Exelixis Inc

$51.24

+1.2%

CYTK

Cytokinetics Inc

$74.13

+0.9%

MDGL

Madrigal Pharmaceuticals Inc

$507.56

+0.0%

HALO

Halozyme Therapeutics Inc

$98.66

-2.0%